ODTC — Odonate Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview
Odonate Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Odonate Therapeutics - Qtrly Loss Per Share Of $0.90
Odonate Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Odonate Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Odonate Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Odonate Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Carnival Corp, Astrotech, UTime Ltd, Odonate Therapeutics
Odonate to shut shop after scrapping lead drug, shares sink to record low
U.S. STOCKS ON THE MOVE-Tesla, Applied Materials, SVB Financial, Support.Com
U.S. STOCKS ON THE MOVE-Tesla, General Motors, Support.com, Kansas City Southern, RLX Technology
U.S. STOCKS ON THE MOVE-premarket
Odonate: Falls on stopping development of chemotherapy drug candidate
NASDAQ RESUMED AT 08:30 AM
Brief: Odonate Therapeutics Announces Discontinuation Of Development Of Tesetaxel
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM